Categories Uncategorized

Marijuana Company of America Inc. (MCOA) Promotes Brand During Super Bowl and Hollywood Events

  • February events have and will continue to provide the company with opportunities to increase its recognition amid Super Bowl and pre-Academy Awards gatherings
  • Marijuana Company of America Inc. upgraded its market tier to the OTCQB Venture Exchange in December
  • The company is aggressively pursuing a strategy of building a following for its hemp products by marketing to celebrities and pro athletes

Amid the rise of the cannabis industry and the high degree of attention that consumers and investors alike are paying to the varied applications of the plant and its derivatives, Marijuana Company of America Inc. (OTCQB: MCOA) is raising its profile as a provider of high-quality hemp and cannabidiol (CBD)-infused products. Following the company’s upgrading of its trading tier to the OTCQB Venture Exchange in December, MCOA began working to improve its brand presence through celebrity access.

MCOA’s wholly owned subsidiary, hempSMART, led the company’s offense at Super Bowl LIII promotional events earlier this month, presenting its CBD-infused product line to a number of professional athletes, NFL coaches, actors, musicians and other persons of interest at events such as Ray Lewis’ ‘Ray of Hope’ Foundation’s Gold Jacket for a Purpose gathering and activities at the Ice Box Club in Atlanta.

The hempSMART Brain and hempSMART Pain Cream products, particularly, were gifted to notable sports and entertainment industry attendees such as Ray Lewis, Deion Sanders, Andre Reed, Marshawn Lynch, Tyreek Hill, Larry Fitzgerald, Terrell Owens, Candace Parker, Jon Stewart, Quincy Jones, Malcolm Jenkins, Von Miller, Brandon Marshall, Eddie George, Adrian Peterson, Maroon 5 and the Backstreet Boys, according to a news release about the annual finale to the U.S. pro football season (http://cnw.fm/LB89d).

“Attending the Super Bowl LIII events this past weekend provided a great opportunity for well-known professional athletes and celebrities to discover how amazing and beneficial our products can be for them,” Marijuana Company of America CEO Donald Steinberg stated in the news release.

MCOA further intends to promote its brand to numerous Hollywood celebrities during giveaways at a pre-Academy Awards event later in the month as part of the strategy.

The company’s website notes that the wellness industry is growing rapidly and is now generating $1.9 trillion in sales per year. The hempSMART full-spectrum extracts utilize Mother Nature’s own elements to support the body’s endocannabinoid system in balancing every cell and system of the body (http://cnw.fm/PKx3v).

MCOA’s business model includes advancing a diverse portfolio of business segments that work together synergistically, and the hemp-related brands are positioning themselves to capture market share as a series of developments advance hemp’s potential.

Perhaps key among those developments in the United States has been the federal government’s recognition of potential benefits from cannabis products after decades of categorizing the plant as something with no established medical benefit. In December, a long-debated agricultural policy update to national legislation resulted in congressional and presidential approval of measures to make hemp a legal crop under strict regulations, thus opening the door to individual states interested in developing their own agricultural industries with large-scale production of the non-psychoactive cannabis variety (http://cnw.fm/0XCjv).

Grand View Research analysts have issued a forecast anticipating that the global industrial hemp market will grow from an estimated $3.9 billion in 2017 (http://cnw.fm/vEfj4) to about $10.6 billion by 2024 (http://cnw.fm/YG46l).

For more information, visit the company’s website at www.MarijuanaCompanyofAmerica.com

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) PsychedelicNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, PNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. PNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, PNW brings its clients unparalleled visibility, recognition and brand awareness. PNW is where news, content and information converge.

Receive Text Alerts from PsychedelicNewsWire: Text “Cannabis” to 888-902-4192

For more information please visit https://www.psychedelicnewswire.com and or https://PsychedelicNewsWire.News

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/disclaimer/

PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com

Chris@PNW

Share
Published by
Chris@PNW

Recent Posts

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Pursues Dual Pathway for Preservative-Free Ketamine-Based Therapies

The company has refiled its Abbreviated New Drug Application (“ANDA”) for KETAFREE(TM), a preservative-free IV…

15 hours ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Gains FDA Nod for Preservative-Free Ketamine Suitability Petition

FDA grants NRx Pharmaceuticals approval of a Suitability Petition for single-patient preservative-free ketamine. The decision…

1 week ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Secures FDA Fast Track for IV Ketamine Formulation NRX-100 in Suicidal Depression

The FDA designation expands the drug’s potential patient pool tenfold, to an estimated 13 million…

1 month ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Seeks FDA Ban on Toxic Ketamine Preservative

NRx Pharmaceuticals has filed a Citizen Petition with the FDA to remove benzethonium chloride from…

2 months ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Subsidiary to Acquire 49% Stake in Prominent Florida Neuropsychiatry Clinic

The acquisition of Cohen and Associates, a respected interventional psychiatry practice, by NRx subsidiary HOPE…

3 months ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Applies for FDA Commissioner’s National Priority Voucher for IV Ketamine NRX-100

The new FDA voucher program aims to speed approval of drugs aligned with national health…

4 months ago